AZTA250117P30000
- 1.45
- 0.000.00%
Azenta Newsroom
Why Azenta, Inc. (NASDAQ:AZTA) Could Be Worth Watching
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Azenta Price Target Maintained With a $60.00/Share by Stephens & Co.
Evercore Maintains Azenta(AZTA.US) With Hold Rating, Maintains Target Price $50
Azenta (NASDAQ:AZTA) Shareholders Have Endured a 51% Loss From Investing in the Stock Three Years Ago
2024's 'Biggest Loses' That Could See Reversal in 2025
Quantum Computing, BlackBerry And Lucid Group Are Among Top Mid Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Azenta (AZTA) Surges 7.2%: Is This an Indication of Further Gains?
Azenta Raised to Overweight From Equal-Weight by Stephens & Co.
Azenta Analyst Ratings
Stephens Upgrades Azenta(AZTA.US) to Buy Rating, Raises Target Price to $60
An Intrinsic Calculation For Azenta, Inc. (NASDAQ:AZTA) Suggests It's 20% Undervalued
Is It Time To Consider Buying Azenta, Inc. (NASDAQ:AZTA)?
Dentsply Sirona Names Herman Cueto Interim Finance Chief
Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks
Azenta | 10-K: FY2024 Annual Report
Azenta Up Over 9%, On Track for Largest Percent Increase Since November 2023 -- Data Talk
Azenta Shares Are Trading Higher After the Company Announced It Will Join the S&P SmallCap 600.
Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday
Flex to Replace Azenta in S&P MidCap 400 Index